Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $8.1350 (0.87%) ($8.1350 - $8.1350) on Mon. Jan. 23, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.67% (three month average) | RSI | 43 | Latest Price | $8.1350(0.87%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -0.7% a day on average for past five trading days. | Weekly Trend | EDIT declines -4.6% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) XBI(70%) IBB(56%) IWC(52%) IWO(49%) IWM(48%) | Factors Impacting EDIT price | EDIT will decline at least -2.335% in a week (0% probabilities). VIXM(-17%) SMH(-8%) UUP(-6%) TBT(-4%) VXX(-2%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.335% (StdDev 4.67%) | Hourly BBV | 1.3 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-0.38(-104.67%) | Resistance Level | $8.52 | 5 Day Moving Average | $8.09(0.56%) | 10 Day Moving Average | $8.26(-1.51%) | 20 Day Moving Average | $8.52(-4.52%) | To recent high | -38.5% | To recent low | 4.2% | Market Cap | $505m | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |